Loading
Teijin Limited, a Japanese conglomerate established in Tokyo in 1918, operates on a global scale across diverse sectors. Its core businesses encompass advanced materials, including fibers, films and sheets, and composites, as well as significant operations in healthcare and information technology. The company's materials division provides a comprehensive range of products such as high-performance aramid, carbon, and oxidized PAN fibers, along with various polyethylene materials. This segment also offers specialized items like polytrimethylene telephthalate products, artificial leather materials, polyester nanofibers, and recycled polyester fibers. Its offerings extend to polycarbonate, high-density polyethylene porous, and microporous films and sheets, in addition to PC and polyphenylene sulfide resins, molded parts, and additives. Teijin is also a specialist in composite materials, notably developing lightweight glass and carbon fiber reinforced solutions designed for the automotive industry. In the healthcare sector, Teijin develops pharmaceuticals aimed at treating bone and joint, respiratory, and cardiovascular and metabolic diseases, among others. Furthermore, it supplies an extensive array of medical devices and services, including home oxygen therapy equipment, non-invasive positive pressure ventilation systems, rehabilitation tools, and devices for sleep-disordered breathing. The company also provides a sonic accelerated fracture healing system, community-based integrated care systems, orthopedic implantable devices, and functional food ingredients. Within its IT operations, Teijin offers innovative solutions such as Recopic, a radio-frequency identification (RFID) technology tailored for efficient inventory management. Beyond its product lines, the company is actively involved in engineering solutions, tackling critical global challenges related to environmental pollution, ensuring energy supply stability, and addressing the impact of an aging workforce population.
Latest quote
¥1,719
+¥9.00 · +0.53%
Regular session · JST · Market data may be delayed.
Teijin Limited, a Japanese conglomerate established in Tokyo in 1918, operates on a global scale across diverse sectors. Its core businesses encompass advanced materials, including fibers, films and sheets, and composites, as well as significant operations in healthcare and information technology. The company's materials division provides a comprehensive range of products such as high-performance aramid, carbon, and oxidized PAN fibers, along with various polyethylene materials. This segment also offers specialized items like polytrimethylene telephthalate products, artificial leather materials, polyester nanofibers, and recycled polyester fibers. Its offerings extend to polycarbonate, high-density polyethylene porous, and microporous films and sheets, in addition to PC and polyphenylene sulfide resins, molded parts, and additives. Teijin is also a specialist in composite materials, notably developing lightweight glass and carbon fiber reinforced solutions designed for the automotive industry. In the healthcare sector, Teijin develops pharmaceuticals aimed at treating bone and joint, respiratory, and cardiovascular and metabolic diseases, among others. Furthermore, it supplies an extensive array of medical devices and services, including home oxygen therapy equipment, non-invasive positive pressure ventilation systems, rehabilitation tools, and devices for sleep-disordered breathing. The company also provides a sonic accelerated fracture healing system, community-based integrated care systems, orthopedic implantable devices, and functional food ingredients. Within its IT operations, Teijin offers innovative solutions such as Recopic, a radio-frequency identification (RFID) technology tailored for efficient inventory management. Beyond its product lines, the company is actively involved in engineering solutions, tackling critical global challenges related to environmental pollution, ensuring energy supply stability, and addressing the impact of an aging workforce population.
Day range
Current ¥1,719
52-week range
Current ¥1,719
Regular session · JST · Market data may be delayed.
Teijin Limited, a Japanese conglomerate established in Tokyo in 1918, operates on a global scale across diverse sectors. Its core businesses encompass advanced materials, including fibers, films and sheets, and composites, as well as significant operations in healthcare and information technology. The company's materials division provides a comprehensive range of products such as high-performance aramid, carbon, and oxidized PAN fibers, along with various polyethylene materials. This segment also offers specialized items like polytrimethylene telephthalate products, artificial leather materials, polyester nanofibers, and recycled polyester fibers. Its offerings extend to polycarbonate, high-density polyethylene porous, and microporous films and sheets, in addition to PC and polyphenylene sulfide resins, molded parts, and additives. Teijin is also a specialist in composite materials, notably developing lightweight glass and carbon fiber reinforced solutions designed for the automotive industry. In the healthcare sector, Teijin develops pharmaceuticals aimed at treating bone and joint, respiratory, and cardiovascular and metabolic diseases, among others. Furthermore, it supplies an extensive array of medical devices and services, including home oxygen therapy equipment, non-invasive positive pressure ventilation systems, rehabilitation tools, and devices for sleep-disordered breathing. The company also provides a sonic accelerated fracture healing system, community-based integrated care systems, orthopedic implantable devices, and functional food ingredients. Within its IT operations, Teijin offers innovative solutions such as Recopic, a radio-frequency identification (RFID) technology tailored for efficient inventory management. Beyond its product lines, the company is actively involved in engineering solutions, tackling critical global challenges related to environmental pollution, ensuring energy supply stability, and addressing the impact of an aging workforce population.
Day range
Current ¥1,719
52-week range
Current ¥1,719
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (JPY) | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 873.19B JPY | 1.01T JPY | 960.46B JPY | 1.02T JPY | 926.05B JPY |
| Cost of goods sold | 711.23B JPY | 814.02B JPY | 749.82B JPY | 799.99B JPY | 684.78B JPY |
| Gross profit | 161.96B JPY | 191.45B JPY | 210.64B JPY | 218.76B JPY | 241.27B JPY |
| Research and development | — | 30.9B JPY | 42.56B JPY | 31.94B JPY | 33.34B JPY |
| Selling, general, and administrative | 231.32B JPY | 239.43B JPY | 182.11B JPY | 173.97B JPY | 163.72B JPY |
| Operating expenses | 231.32B JPY | 270.33B JPY | 224.67B JPY | 205.9B JPY | 197.06B JPY |
| Interest income | 4.16B JPY | 2.94B JPY | 2.61B JPY | 1.26B JPY | 468M JPY |
| Interest expense | 9.47B JPY | 11.07B JPY | 12.48B JPY | 7.08B JPY | 3.25B JPY |
| Depreciation and amortization | 60.32B JPY | 71.03B JPY | 78.03B JPY | 78.77B JPY | 68.82B JPY |
| Operating income | −69.36B JPY | −78.88B JPY | −14.03B JPY | 12.86B JPY | 44.21B JPY |
| Net income | −88B JPY | 28.35B JPY | −11.71B JPY | −17.7B JPY | 23.16B JPY |
Company facts updated Sep 17, 2026.
Reported history and fiscal-year consensus
Reported history and fiscal-year consensus
| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Sep 28, 2016 | 1:5 | — | — |
Effective Sep 28, 2016
1:5
Funds reporting this stock among their holdings, ordered by reported position size.
NEXT FUNDS TOPIX Exchange Traded Fund1306.T9.34B0.03%34.35T JPY0.05%¥426.8+0.68%
Next Funds Nikkei 225 ETF1321.T3.12B0.02%16.99T JPY0.09%¥66,370+0.29%
Nikko Exchange Traded Index Fund 2251330.T1.49B0.02%8.31T JPY0.08%¥66,490+0.30%
iShares Core TOPIX ETF1475.T777.23M0.03%2.91T JPY0.05%¥420+0.77%
iShares Core Nikkei 225 ETF1329.T358.44M0.02%2.03T JPY0.05%¥6,641+0.24%
Avantis International Small Cap Value ETFAVDV60.39M0.30%20.23B USD0.36%$110.440.00%
Vanguard Total International Stock ETFVXUS28.97M0.00%646.2B USD0.05%$85.41-0.33%
Vanguard FTSE Developed Markets ETFVEA19.83M0.01%323.8B USD0.03%$71.26-0.38%NEXT FUNDS TOPIX Exchange Traded Fund1306.TNext Funds Nikkei 225 ETF1321.TNikko Exchange Traded Index Fund 2251330.TiShares Core TOPIX ETF1475.TiShares Core Nikkei 225 ETF1329.TAvantis International Small Cap Value ETFAVDVVanguard Total International Stock ETFVXUSVanguard FTSE Developed Markets ETFVEAAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
